Biosafety Testing Throughout the Drug Development Cycle

12th September 2018

Category: Biosafety

Tags: ,

By: Daniel Cozens - Scientist, Biosafety,

Biosafety Testing from Cell Line Development Through to Lot Release For the release of biopharmaceutical drugs onto the market, products must be shown to be safe. Regulatory bodies such as the US Food & Drug Administrators (FDA) and the Medicines and Healthcare Regulatory Agency (MHRA) require products are tested for compliance before release. This involves a More

Sign-up to our newsletter to be the first to hear about our new services & offers

Sign-up to our newsletter to be the first to hear about our new services & offers

Enter your email address to subscribe to our newsletter which provides information about our services. By subscribing, you are agreeing to the processing of your personal information for this purpose as set out in our privacy policy